A-shares rallied this week, and some of the early hot-selling stocks on the disk gradually became cold. At the same time, the big health industry represented by medical services and medical devices continued to receive funding attention. According to the analysis, with the advent of an aging society and the gradual advancement of the national medical reform program, the health service industry will usher in a huge growth space and become the focus of many venture capital institutions and capital. Medical equipment welcomes domestic alternative opportunities, seven main lines can be nuggets With the increase of the aging population, the demand for medical devices has begun to erupt, and the industry has entered a period of rapid growth, especially domestic medical devices. According to the data released by the Ministry of Industry and Information Technology, in the first four months of 2016, the pharmaceutical industry's above-scale enterprises achieved a revenue of 867.923 billion yuan, a year-on-year increase of 10.4%. The fastest growth of the main business income was medical equipment and equipment, and Chinese medicine drinks. . The “13th Five-Year Plan†and the “Made in China†upgrade plan have raised the innovative R&D and quality upgrade of domestic medical devices to an unprecedented height. Strong policy support Since the beginning of this year, medical devices have received strong support from the policy. Regardless of the "13th Five-Year Plan" or the "Made in China" promotion plan, etc., the innovative research and development and quality upgrade of domestic medical devices have been upgraded to an unprecedented height - the position of national strategy. Domestic medical devices have ushered in a good time for development. On June 20, the State Food and Drug Administration issued the “Letter for Soliciting Opinions on the Priority Approval Process for Medical Devicesâ€. This is the second time after the implementation of the “Special Approval Process for Innovative Medical Devices (Trial)†in 2014. The scope of application of the priority review will be expanded to include major national science and technology projects or national key research and development programs as well as clinically urgently needed products, including IVD, video, nuclear medicine equipment, etc., combined with the “Accurate Medical Research†published by the Health Planning Commission 2016. The main content of the annual project announcement is to realize the localization of medical devices. From the terminal point of view, in the medical reform program in the pilot province of Hunan Province, the pilot city of Shandong Jinan, and the capital Beijing, etc., it is proposed to encourage the preferential use of domestic equipment. On the other hand, from the latest hospital control fees issued by the National Health and Family Planning Commission, the national medical expenses growth rate has dropped from 20% to less than 10% at the end of 2017. One of the key points of its control measures is to prioritize the purchase of domestic high-value consumables. Debon Securities pointed out that the growth of domestic medical devices in the future is worth looking forward to. Botanical Extract refers to the material extracted or processed from plants (all or part of plants) with appropriate solvents or methods, which can be used in the pharmaceutical industry, food industry, health industry, beauty industry and other industries. Botanical Extract ,Andrographolide Powder ,Kaempferol Powder, Isolated Soy Protein Meat Xi'an Double H Health Technology Co., Ltd , https://www.xadoubleh.com